Drugs / Thrombin JMI
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT00814333 | Dec 2008 → Aug 2011 | — | University of Kansas Medical Center | Terminated | No outcome recorded Stop: Enrollment |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06379724 Comparator | Jul 2024 → Dec 2026 expected | — | University of Kansas Medical Center | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Thrombin-JMI | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00814333 ↗ |
| Route | Topical | “to nasal mucosa via syringe spray applicator” NCT00814333 ↗ |